Medhi Hamadani

Socioeconomic and Racial Disparity in Chimeric antigen receptor T cell (CAR T) Therapy Access.

M. Mushtaq, J. McGuirk, L. Shune, 2022, Transplantation and cellular therapy.

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

J. Wingard, A. Mishra, M. Levis, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.

M. Zangari, F. van Rhee, B. Dhakal, 2024, Bone marrow transplantation.

Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study

S. Chhabra, B. Dhakal, S. Radhakrishnan, 2023, Bone marrow transplantation.

Efficacy of multiple SARS-CoV-2 vaccine doses in patients with B-cell hematologic malignancies receiving CAR-T therapy - A contemporary, cohort analysis.

T. Fenske, B. Dhakal, M. B. Abid, 2023, Transplantation and cellular therapy.